INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
SE

Sabar Karimah Es

DirectorCIK 0001873796

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 2
Max Insider Score26
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$298K
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    CAPRICOR THERAPEUTICS, INC.Director · Jan 7, 2026
26
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL
$1.85M
61.3K sh
Mar 31, 2026
Apr 1, 2026
traded Mar 31, 2026
+1d
SEC FORM 4

Evidence

1
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$261K
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

9
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence